AI-Based Federated Learning for Multicenter Medical Imaging

Abstract

Artificial intelligence (AI) and federated learning (FL) have emerged as transformative approaches in medical imaging, enabling the development of robust diagnostic models while preserving patient privacy across multiple centers. This review examines the current state and clinical implications of AI-based federated learning for multicenter medical imaging, emphasizing scientific evidence, pathophysiological mechanisms, and practical deployment. Special attention is given to epidemiological impacts, clinical features, diagnostic considerations, management strategies, recent advancements, and guideline-driven recommendations, offering a comprehensive perspective for healthcare professionals.

Introduction

The integration of artificial intelligence into medical imaging has revolutionized diagnostic accuracy and workflow efficiency. Traditional centralized AI training requires data aggregation, often restricted by privacy regulations and logistical limitations, especially in multicenter collaborations. Federated learning circumvents these challenges by enabling decentralized model training across various institutions without direct data sharing. This paradigm shift holds profound implications for the scalability, generalizability, and ethical compliance of AI-driven imaging solutions in clinical practice. As multicenter studies increasingly form the backbone of evidence-based medicine, the application of federated learning in this context warrants a detailed exploration.

Epidemiology / Disease Burden

The global burden of disease necessitates large, heterogeneous datasets to build AI models that generalize across diverse populations. Multicenter imaging studies have become essential for conditions such as cancer, cardiovascular disease, and neurodegenerative disorders. However, data silos and privacy concerns hinder collaborative research. Federated learning addresses these obstacles, allowing tens to hundreds of hospitals to collaboratively train AI models. The approach is particularly relevant in rare diseases and pediatric populations, where single-center data are insufficient for high-performance algorithms. Recent multicenter trials employing FL have demonstrated improved model performance and reduced biases related to demographic variability, supporting its epidemiological value.

Pathophysiology

AI models in medical imaging often rely on learning complex, pathophysiological patterns from radiological datasets. Federated learning leverages distributed local computation, wherein each participating center trains the model on its own data, capturing site-specific imaging characteristics, including scanner differences and population heterogeneity. The aggregated model, updated via secure parameter sharing, better reflects the multifaceted nature of disease manifestations. For instance, in oncology, AI-based FL captures subtle morphological and textural changes across institutions, enhancing tumor detection and grading accuracy. By encompassing broader pathophysiological spectra, FL-trained models mitigate overfitting to single-center idiosyncrasies and better represent real-world variability.

Risk Factors

Federated learning inherently addresses several risk factors associated with traditional AI model development, such as data privacy breaches and limited generalizability. However, new risks arise, including those related to model inversion attacks and aggregation bias. Robust encryption protocols and secure multiparty computation are critical to mitigate these risks. Additionally, technical disparities between centers, such as scanner hardware or imaging protocol differences, can introduce systematic biases. Understanding and controlling for such risks are paramount for the safe and effective deployment of federated AI models in clinical imaging workflows.

Clinical Features

In medical imaging, clinical features extracted by AI models range from radiomic signatures to quantitative lesion measurements. Federated learning allows these features to be learned from a wider spectrum of patient populations and disease subtypes, enhancing model robustness. For example, in multicenter chest CT studies for COVID-19, FL-based models accurately identified ground-glass opacities and consolidations, even when imaging parameters varied between institutions. The clinical utility of these features extends to risk stratification, prognostication, and decision support, ultimately facilitating personalized patient care on a global scale.

Diagnosis

Diagnostic accuracy is the cornerstone of AI applications in medical imaging. Federated learning enhances diagnostic performance by enabling the aggregation of diverse, multicenter datasets, thus reducing overfitting and increasing external validity. Recent studies have demonstrated that FL-trained models outperform or match centrally trained models in detecting pulmonary nodules, brain tumors, and diabetic retinopathy. Moreover, federated AI systems can continuously learn from new data without requiring data transfer, supporting real-time model improvement. This decentralized approach aligns with evolving regulatory requirements for clinical AI deployment, including GDPR and HIPAA compliance.

Treatment & Management

AI-based federated learning in imaging extends its impact beyond diagnosis, influencing treatment planning, response assessment, and disease monitoring. In oncology, FL models have been used to predict treatment response using radiomic and deep learning features derived from pre- and post-therapy scans. Similarly, in cardiology, federated AI algorithms have facilitated automated segmentation of cardiac structures, guiding interventional planning and therapy optimization. By leveraging multicenter data, these models accommodate variations in treatment protocols and patient demographics, supporting evidence-based, individualized management strategies across healthcare systems.

Recent Advances / Emerging Therapies

The field of federated learning for medical imaging is advancing rapidly, with innovations in privacy-preserving technologies, model aggregation methods, and cross-institutional collaboration. Differential privacy, secure aggregation, and homomorphic encryption are being integrated into FL frameworks to bolster data security. Algorithmic advances, such as adaptive federated optimization and personalized federated learning, address center-specific performance disparities. Large-scale initiatives, including the Federated Tumor Segmentation (FeTS) Challenge and EU-funded projects, are pioneering real-world FL deployment, demonstrating feasibility for regulatory-grade clinical AI products. These developments herald a new era of collaborative, privacy-conscious medical research and care delivery.

Guideline Recommendations

Professional societies and regulatory bodies are beginning to recognize the value of federated learning in clinical AI. The Radiological Society of North America (RSNA) and European Society of Radiology (ESR) advocate for multicenter validation and data privacy compliance in AI development. Emerging guidelines emphasize the importance of transparent model reporting, robust validation across diverse cohorts, and ongoing post-deployment monitoring. Adoption of federated learning aligns with these recommendations, facilitating guideline-concordant AI model development that is scalable, secure, and clinically relevant. Institutions are encouraged to establish governance frameworks and invest in FL infrastructure to support future collaborative research endeavors.

Conclusion

AI-based federated learning represents a paradigm shift in multicenter medical imaging, addressing longstanding challenges of data privacy, generalizability, and collaborative research. Its adoption enables the creation of clinically robust, ethically compliant AI models, accelerating innovation in diagnostic accuracy, treatment planning, and patient outcomes. As technological and regulatory landscapes evolve, federated learning is poised to become the cornerstone of future medical imaging research and practice.